| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |